CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$4.27
+3.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.20x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.18x
- Price / sales
- 38.67x
- Price / cash flow
- -1.06x
Enterprise value
- Enterprise value
- $12.0M
- EV / sales
- 37.76x
- EV / EBITDA
- -1.04x
- EV / EBIT
- -0.97x
- Market cap
- $12.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026